Yekaterina Chudnovsky
Director/Board Member bei ELICIO THERAPEUTICS, INC.
Vermögen: 10 Mio $ am 31.03.2024
Profil
Yekaterina Chudnovsky is currently the Chairman at Gi Research Foundation, Director at Elicio Therapeutics, Inc. (United States), Director at xCures, Inc., Independent Director at Immix Biopharma, Inc., Independent Director at Elicio Therapeutics, Inc., and Director at Gkcc LLC.
She has an undergraduate degree from Northwestern University and a graduate degree from DePaul University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMIX BIOPHARMA, INC.
12,69% | 22.08.2023 | 3 241 076 ( 12,69% ) | 10 Mio $ | 31.03.2024 |
ELICIO THERAPEUTICS, INC
-.--% | 19.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Yekaterina Chudnovsky
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director/Board Member | 01.10.2022 |
| IMMIX BIOPHARMA, INC. | Director/Board Member | 22.08.2023 |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Director/Board Member | - |
xCures, Inc.
 xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Director/Board Member | - |
| Gkcc LLC | Director/Board Member | - |
Ausbildung von Yekaterina Chudnovsky
| Northwestern University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMIX BIOPHARMA, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
xCures, Inc.
xCures, Inc. Packaged SoftwareTechnology Services xCures, Inc. engages in the development of artificial intelligence (AI) based precision oncology platform. It offers patients and physicians an individualized treatment options and facilitates access via reimbursement, clinical trials, and access support. The company was founded by Jeff Shrager and Jay Marty Tenenbaum in 2018 and is headquartered in Los Altos, CA. | Technology Services |
| Gkcc LLC |
